Association between Immunization Status and Encephalitis in Pediatric Measles Cases
DOI:
https://doi.org/10.51985/Keywords:
Measles; Encephalitis; Immunization; Vaccination; Child.Abstract
Objective: To examine the association between measles immunization status and encephalitis among hospitalized children aged 1–5 years with measles.
Study Design and Setting: Analytical cross-sectional study conducted in the Department of Pediatric Medicine, Allied Hospital, Faisalabad.
Methodology: Total 133 children aged 1–5 years with clinically compatible measles were enrolled. Children with chronic systemic disease, immunocompromised status, or hereditary syndromes were excluded. Immunization status was verified from the EPI vaccination card. Measles case classification followed WHO surveillance criteria; measles-specific IgM and/or RT-PCR was used for laboratory confirmation. Encephalitis was defined by sustained altered mental status with supportive neurological features. Pearson chi-square testing was used for the primary 2×2 comparison because expected cell counts were adequate; two-sided Fisher exact testing was reported as a sensitivity analysis. Statistical significance was defined as p<0.05.
Results: Mean age was 3.12 ± 1.18 years. Of 133 children, 46 (34.6%) were fully immunized and 87 (65.4%) were unimmunized/incompletely immunized. Encephalitis occurred in 21/133 children (15.8%; 95% CI 10.6%–22.9%): 3/46 fully immunized children (6.5%) and 18/87 un-immunized/incompletely immunized children (20.7%). The crude sample OR was 3.74 with a conditional exact 95% CI of 0.996–20.81; the crude PR/RR was 3.17 (95% CI 0.95–8.32) and the RD was 14.2 percentage points (95% CI 1.0–24.7). Pearson chi-square p=0.033; two-sided Fisher exact p=0.044. Delayed presentation (>7 days) was also associated with encephalitis in unadjusted analysis.
Conclusion: Among hospitalized pediatric measles cases, un-immunized/incompletely immunized status was associated with a higher observed frequency of encephalitis than full immunization.
Downloads
References
1. López-Perea N, Fernández-García A, Echevarría JE, de Ory
F, Pérez-Olmeda M, Masa-Calles J. Measles in vaccinated
people: epidemiology and challenges in surveillance and
diagnosis in the post-elimination phase. Spain, 2014–2020.
Viruses. 2021;13(10):1982. doi:10.3390/v13101982.
2. Rabaan AA, Al Mutair A, Alhumaid S, Garout M, Alsubki
RA, Alshahrani FS, et al. Updates on measles incidence and
eradication: emphasis on the immunological aspects of measles
infection. Medicina (Kaunas). 2022;58(5):680. doi:10.3390/
medicina58050680.
3. Parums DV. A review of the resurgence of measles, a vaccinepreventable disease, as current concerns contrast with past
hopes for measles elimination. Med Sci Monit. 2024;30.
doi:10.12659/MSM.944436.
4. Cherry JD. Ongoing measles in the developed and developing
world. J Pediatric Infect Dis Soc. 2024;13(4):187-189.
doi:10.1093/ jpids/piae018.
5. Costales C, Sahoo MK, Huang C, Guimaraes CV, Born D,
Kushner L, et al. Vaccine-associated measles encephalitis in
immunocompromised child, California, USA. Emerg Infect
Dis. 2022;28(4):906-908. doi:10.3201/eid2804.212357.
6. Johnson SM, Hassell J, Manning GLP, Sudhakar S, Brierley
J, Grandjean L, et al. Acute post-measles encephalitis in a
returning traveller: highlighting the need for MMR vaccination.
Rev Med Virol. 2024;34(6). doi:10.1002/rmv.2588.
7. Fappani C, Gori M, Canuti M, Terraneo M, Colzani D, Tanzi
E, et al. Breakthrough infections: a challenge towards measles
elimination? Microorganisms. 2022;10(8):1567. doi:10.3390/
microorganisms10081567.
8. Turaiche M, Grigoras ML, Bratosin F, Bogdan I, Bota AV,
Cerbu B, et al. Disease progression, clinical features, and risk
factors for pneumonia in unvaccinated children and adolescents
with measles: a re-emerging disease in Romania. Int J Environ
Res Public Health. 2022;19(20):13165. doi:10.3390/
ijerph192013165.
9. Ullah F, Muhammad T, Ullah F, Naz R, Khan B, Qazi S.
Frequency of measles related complications in hospitalized
children. Pak J Med Health Sci. 2023;17(1):548-550. doi:10.
53350/pjmhs2023171548.
10. Kulsoom S, Soomro S, Junejo S, Anjum M, Waseem H,
Akram M. Clinical presentation, complications and outcome
of measles in pediatric population at tertiary care hospital.
Pak J Health Sci. 2023;4(3):50-53. doi:10.54393/pjhs.v4i03.
624.
11. Mawlood SK, Al-Ani MM, Al-Ani RM, Alshibib A. Impact
of measles vaccination on clinical characteristics and outcomes
in children in Ramadi, Iraq. World J Clin Pediatr. 2025;14(3):
107253. doi:10.5409/wjcp.v14.i3.107253.
12. Alsulaiman JW, Kheirallah KA, Alrawashdeh A, Abu Sanad
Z, Al-Mnayyis AM, Yassin A, et al. Clinical and demographic
characteristics of hospitalized pediatric measles cases; the
2023 outbreak in Northern Jordan. Infect Drug Resist.
2025;18:1773-1783. doi:10.2147/IDR.S518009.
13. Bursal B, Çelik T, Bingöl Ý, Tosun D, Tuncay SA, Daðtekin
ZK, et al. Resurgent measles in Türkiye: predictors of severe
disease in a nationwide paediatric cohort, 2023. Eur J Pediatr.
2025;184(11):719. doi:10.1007/s00431-025-06539-1.
14. Mathis AD, Routh JA, Keating MK, Patel M, Redd SB,
Clemmons NS, et al. Measles update—United States, January
1–April 17, 2025. MMWR Morb Mortal Wkly Rep.
2025;74(14):233-238. doi:10.15585/mmwr.mm7414a1.
15. Endalamaw D, Mekonen A, Geremew D, Ambaw F, Adane
S, Baye M, et al. Measles vaccine effectiveness in African
children: a systematic review and meta-analysis. BMC Infect
Dis. 2024;24:1310. doi:10.1186/s12879-024-10239-w.
16. Comfort H, Lafta RK, Flaxman AD, Hagopian A, Duber HC.
Association between subnational vaccine coverage, migration,
and incident cases of measles, mumps, and rubella in Iraq,
2001–2016. Front Public Health. 2022;9:689458. doi:10.3389/
fpubh.2021.689458.
17. van der Staak M, Ten Hulscher HI, Nicolaie AM, Smits GP,
de Swart RL, de Wit J, et al. Long-term dynamics of measles
virus-specific neutralizing antibodies in children vaccinated
before 12 months of age. Clin Infect Dis. 2025;80(4):904-
910. doi:10.1093/cid/ciae537.
18. Mohamud AK, Ahmed OA, Ali IA, Dirie NI. Demographical,
clinical, and complication differences between vaccinated
and unvaccinated hospitalized children with measles in
Mogadishu, Somalia: a hospital-based retrospective cohort
study. Ann Med Surg (Lond). 2023;85(5):1550-1556.
doi:10.1097/MS9.0000000000000672
19. Orhan Ö, Solmaz M, Talay MN. Evaluation of measles cases
in a province in South-Eastern Turkey receiving migration
from Syria. Acta Paediatr. 2025;114(5):1051-1056.
doi:10.1111/apa.70008.
20. Kushner LE, Kamens J, Bertaina A, Shyr D, Gans HA. Vaccine
associated measles complicated by suspected measles inclusion
body encephalitis in a pediatric leukemia patient and stem
cell transplant recipient: a focus on clinical evolution and
management. Pediatr Infect Dis J. 2024;43(6):582-586.
doi:10.1097/INF.0000000000004299.
21. Rettenbacher-Riefler S, Holzmann H, Redlberger-Fritz M,
Redlberger-Fritz V, Popow-Kraupp T, Aberle JH, et al. The
unprotected: measles seroprevalence in children during the
first two years of life. Viruses. 2025;17(7):973. doi:10.3390/
v17070973.
22. Ghosh S, Mutasa R, Kang G, Moss WJ, Orenstein WA, Haldar
P, et al. A systematic review and modelling insights of factors
affecting measles vaccine efficacy, effectiveness and
immunogenicity. BMC Med. 2025;23:421. doi:10.1186/s12916
-025-04218-9.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Journal of Bahria University Medical & Dental College is an open access journal and is licensed under CC BY-NC 4.0. which permits unrestricted non commercial use, distribution and reproduction in any medium, provided the original work is properly cited. To view a copy of this license, visit https://creativecommons.org/licenses/by-nc/4.0
